InnoSphere is a medical device company, developing brain stimulation treatments for cognitive disorders, focusing on ADHD.
With its patented technologies, and in collaboration with Yale university and the university of Oxford, InnoSphere achieves significant improvements of ADHD symptoms in its clinical trials at Hadassah Medical Center in Jerusalem and at King’s College of London.
InnoSphere is seeking an Investment of $8M, for obtaining a CE mark under the medical device directive, and reach the European market with a clinical solution